Multi-primer amplification method for barcoding of target nucleic acids

Inventors

May, Andrew • Chen, Peilin • Wang, Jun • Kaper, Fiona • Anderson, Megan

Assignees

Standard Biotools Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11795494-B2

Patent

Publication Date

2023-10-24

Expiration Date


Abstract

In certain embodiments, the present invention provides amplification methods in which nucleotide tag(s) and, optionally, a barcode nucleotide sequence are added to target nucleotide sequences. In other embodiments, the present invention provides a microfluidic device that includes a plurality of first input lines and a plurality of second input lines. The microfluidic device also includes a plurality of sets of first chambers and a plurality of sets of second chambers. Each set of first chambers is in fluid communication with one of the plurality of first input lines. Each set of second chambers is in fluid communication with one of the plurality of second input lines. The microfluidic device further includes a plurality of first pump elements in fluid communication with a first portion of the plurality of second input lines and a plurality of second pump elements in fluid communication with a second portion of the plurality of second input lines.

Core Innovation

The invention describes amplifying a plurality of target nucleic acids by preparing an amplification mixture for each target nucleic acid, where a forward primer and a reverse primer each additionally comprise nucleotide tags. The forward primer comprises a target-specific portion and a first nucleotide tag, and the reverse primer comprises a target-specific portion and a second nucleotide tag, so that the produced amplicons carry the first and second nucleotide tags flanking the target nucleotide sequence.

The invention further adds at least one barcode primer that comprises a barcode nucleotide sequence and a first or second nucleotide tag-specific portion. The barcode nucleotide sequence is incorporated at the 5′ or 3′ end of the target amplicon, and the method uses more than 100 amplification mixtures with a barcode primer concentration that is 2-fold to 5-fold the concentration of the forward or reverse primer.

For genomic DNA, the method produces target amplicons in which at least 50 percent of the target amplicons are present at greater than 50 percent of the average number of copies and less than 2-fold the average number of copies of target amplicons. The document content also emphasizes upstream sample tagging to prevent mislabeling and cross-contamination and to enable chain of custody via tag detection during transfers.

Claims Coverage

Independent claim clm-00001 covers a multi-target amplification workflow that combines forward/reverse nucleotide-tagged primers with at least one barcode primer, uses more than 100 amplification mixtures with a specified barcode-to-forward/reverse primer concentration relationship, and includes a genomic DNA representation/copy-number constraint for the resulting tagged, barcoded amplicons. The inventive features include four elements.

Nucleotide-tagged forward and reverse primers

A forward primer comprising a target-specific portion and additionally a first nucleotide tag, and a reverse primer comprising a target-specific portion and additionally a second nucleotide tag, wherein the forward and reverse primers anneal to sites in the target nucleic acids separated by intervening target nucleotide sequence, producing amplicons with the first and second nucleotide tags flanking the target nucleotide sequence.

Barcode primer with tag-specific portion

At least one barcode primer comprising a barcode nucleotide sequence and a first or second nucleotide tag-specific portion, wherein the barcode nucleotide sequence is present at the 5′ or 3′ end of the target amplicon.

Barcode primer concentration relationship and large number of mixtures

Preparing at least one barcode primer and more than 100 amplification mixtures, wherein the concentration of the barcode primer is 2-fold to 5-fold the concentration of the forward or reverse primer.

Genomic DNA representation and copy-number constraint

When the target nucleic acids are genomic DNA, producing a plurality of target amplicons wherein at least 50 percent of the target amplicons are present at greater than 50 percent of the average number of copies of target amplicons and less than 2-fold the average number of copies of target amplicons.

Overall, the claim coverage centers on producing target amplicons that simultaneously carry first and second nucleotide tags flanking the target sequence and a barcode nucleotide sequence at an amplicon end, while using a specified barcode primer concentration ratio and preparing more than 100 amplification mixtures. For genomic DNA, the method is further characterized by a quantified representation/copy-number constraint for at least 50 percent of the target amplicons.

Stated Advantages

Improved prevention of mislabeling and cross-contamination via sample tagging and tag detection during transfers.

Enables chain of custody via tag detection during transfers.

For genomic DNA, provides target amplicon representation constrained such that at least 50 percent of the target amplicons are present within greater than 50 percent and less than 2-fold of the average number of copies.

Documented Applications

Upstream sample tagging to prevent mislabeling and cross-contamination and to enable chain of custody via tag detection during transfers.

Amplification and barcoding of genomic DNA target nucleic acids for downstream workflows that include tagged, barcoded PCR products and representations/coverage constraints reported in examples.

Microfluidic processing concepts are described, including use with a microfluidic Access Array IFC amplification workflow and post-PCR handling concepts referenced in the document content.

Sequencing-related processing is described in the document content, including emulsion PCR and pyrosequencing on a Roche 454 FLX sequencer and representation/coverage evaluation constraints.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.